|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
NZ513935A
(en)
|
1999-02-17 |
2004-02-27 |
Csl Ltd |
Immunogenic complexes and methods relating thereto
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
WO2000061151A2
(en)
|
1999-04-12 |
2000-10-19 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US7479285B1
(en)
|
1999-08-19 |
2009-01-20 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
DE60131430T2
(de)
|
2000-01-14 |
2008-10-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
|
US6552006B2
(en)
|
2000-01-31 |
2003-04-22 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
AU4175101A
(en)
|
2000-02-23 |
2001-09-03 |
Univ California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
|
AU2001256970C1
(en)
|
2000-03-31 |
2008-07-03 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
US6943240B2
(en)
|
2000-09-15 |
2005-09-13 |
Coley Pharmaceuticals Gmbh |
Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist
|
|
US20030049266A1
(en)
|
2000-12-27 |
2003-03-13 |
Fearon Karen L. |
Immunomodulatory polynucleotides and methods of using the same
|
|
KR20020083634A
(ko)
*
|
2001-04-27 |
2002-11-04 |
크레아젠 주식회사 |
수지상 세포를 포함하는 자가면역 질환의 치료용 약제학적조성물 및 이를 이용한 치료방법
|
|
DK2423335T3
(da)
|
2001-06-21 |
2014-08-18 |
Dynavax Tech Corp |
Kimæriske immunmodulatoriske forbindelser og fremgangsmåder til anvendelse deraf
|
|
AU2002326561B2
(en)
|
2001-08-07 |
2008-04-03 |
Dynavax Technologies Corporation |
Immunomodulatory compositions, formulations, and methods for use thereof
|
|
WO2003020884A2
(en)
|
2001-08-14 |
2003-03-13 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Method for rapid generation of mature dendritic cells
|
|
IL160157A0
(en)
|
2001-08-17 |
2004-07-25 |
Coley Pharm Group Inc |
Combination motif immune stimulation oligonucleotides with improved activity
|
|
ES2335979T3
(es)
|
2001-09-14 |
2010-04-07 |
Cytos Biotechnology Ag |
Empaquetamiento de cpg inmunoestimuladores en particulas similares a virus: metodo de preparacion y su uso.
|
|
CA2461877A1
(en)
*
|
2001-09-28 |
2003-04-10 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
AU2002366710A1
(en)
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
|
EP1499187B1
(en)
|
2002-04-04 |
2015-06-17 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
|
CA2483012C
(en)
*
|
2002-04-22 |
2011-05-24 |
Bioniche Life Sciences Inc. |
Oligonucleotide compositions and their use for the modulation of immune responses
|
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
|
AU2003247880B2
(en)
*
|
2002-07-03 |
2010-09-02 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
SG166673A1
(en)
*
|
2002-08-19 |
2010-12-29 |
Coley Pharm Group Inc |
Immunostimulatory nucleic acids
|
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
|
EA008777B1
(ru)
*
|
2002-10-29 |
2007-08-31 |
Коли Фармасьютикал Груп, Лтд. |
Способы и продукты, относящиеся к лечению и предупреждению инфекции вируса гепатита c
|
|
WO2004098491A2
(en)
|
2002-11-01 |
2004-11-18 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES
|
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
|
SI1575977T1
(sl)
*
|
2002-12-23 |
2010-01-29 |
Dynavax Tech Corp |
Imunostimulirni sekvenčni polinukleotidi in postopki za njihovo uporabo
|
|
CA2517839A1
(en)
*
|
2003-03-26 |
2004-10-07 |
Martin F. Bachmann |
Melan-a peptide analogue-virus-like-particle conjugates
|
|
US7537767B2
(en)
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
|
JP4673217B2
(ja)
|
2003-04-23 |
2011-04-20 |
由紀夫 佐藤 |
メチル化ＣｐＧポリヌクレオチド
|
|
KR100872472B1
(ko)
*
|
2003-05-15 |
2008-12-05 |
도꾸리쯔교세이호징 가가꾸 기쥬쯔 신꼬 기꼬 |
면역자극제
|
|
JP3976742B2
(ja)
*
|
2004-02-27 |
2007-09-19 |
江守商事株式会社 |
インターフェロンアルファを誘導する免疫刺激オリゴヌクレオチド
|
|
AU2005335104C1
(en)
|
2004-07-18 |
2010-10-28 |
Csl Limited |
Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
|
|
JP2008000001A
(ja)
*
|
2004-09-30 |
2008-01-10 |
Osaka Univ |
免疫刺激オリゴヌクレオチドおよびその医薬用途
|
|
DE102005005642A1
(de)
*
|
2005-02-06 |
2006-08-10 |
Phenion Gmbh & Co. Kg |
Kosmetische oder pharmazeutische Zubereitungen enthaltend Nukleinsäuren, die zur Ausbildung von stem-loop-Sekundärstrukturen geeignete Sequenzen umfassen
|
|
US8642577B2
(en)
|
2005-04-08 |
2014-02-04 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of poxvirus infections
|
|
PL2380584T3
(pl)
|
2005-07-01 |
2014-03-31 |
Index Pharmaceuticals Ab |
Sposób do immunostymulacji
|
|
US8148341B2
(en)
|
2005-07-01 |
2012-04-03 |
Index Pharmaceuticals Ab |
Method for modulating responsiveness to steroids
|
|
JP5481068B2
(ja)
|
2005-08-31 |
2014-04-23 |
アメリカ合衆国 |
ＣｐＧオリゴデオキシヌクレオチドによって誘発される免疫応答を変化させる方法
|
|
EP1940472A1
(en)
|
2005-10-28 |
2008-07-09 |
Index Pharmaceuticals AB |
Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
|
|
ES2536103T3
(es)
|
2005-11-25 |
2015-05-20 |
Zoetis Belgium S.A. |
Oligorribonucleótidos inmunoestimuladores
|
|
CA2636139A1
(en)
|
2005-12-14 |
2007-06-21 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
US8168164B2
(en)
|
2006-02-03 |
2012-05-01 |
Purdue Research Foundation |
Targeted conjugates and radiation
|
|
CN101460620B
(zh)
|
2006-05-31 |
2012-02-15 |
东丽株式会社 |
免疫刺激寡核苷酸及其药物用途
|
|
EP2530086B1
(en)
|
2006-06-12 |
2019-03-20 |
Kuros Biosciences AG |
Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
|
|
EP1920775B1
(en)
|
2006-10-10 |
2012-12-19 |
Gunther Prof. Dr. Hartmann |
5'Triphosphate oligonucleotide induces anti-viral response
|
|
DK2056845T3
(da)
|
2006-08-08 |
2017-11-27 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Struktur og anvendelse af 5'-phosphat-oligonukleotider
|
|
MX2009003398A
(es)
|
2006-09-27 |
2009-08-12 |
Coley Pharm Gmbh |
Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada.
|
|
EP2104738A2
(en)
*
|
2006-10-26 |
2009-09-30 |
Coley Pharmaceuticals GmbH |
Oligoribonucleotides and uses thereof
|
|
CA2671873C
(en)
|
2006-12-12 |
2018-10-09 |
Brian Stephen Sproat |
Oligonucleotides containing high concentrations of guanine monomers
|
|
US20100285041A1
(en)
|
2007-05-17 |
2010-11-11 |
Eugen Uhlmann |
Class A Oligonucleotides with Immunostimulatory Potency
|
|
HRP20150769T1
(hr)
|
2007-05-18 |
2015-08-28 |
Adiutide Pharmaceuticals Gmbh |
Oligonukleotidni analozi s modificiranim fosfatima, s imunostimulirajuä†om aktivnošä†u
|
|
DE102007044093A1
(de)
*
|
2007-09-14 |
2009-03-19 |
Phenion Gmbh & Co. Kg |
Nukleinsäurehaltige kosmetische und/oder pharmazeutische Zubereitungen zur Induktion antimikrobieller Peptide in epithelialen Deckgeweben
|
|
KR20100068422A
(ko)
|
2007-10-09 |
2010-06-23 |
콜리 파마슈티칼 게엠베하 |
변경된 당 잔기를 함유하는 면역자극성 올리고뉴클레오티드 유사체
|
|
CN102670628B
(zh)
|
2008-01-25 |
2015-11-25 |
奇默里克斯公司 |
治疗病毒感染的方法
|
|
US9738680B2
(en)
|
2008-05-21 |
2017-08-22 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
5′ triphosphate oligonucleotide with blunt end and uses thereof
|
|
HUE028497T2
(en)
|
2008-10-16 |
2016-12-28 |
The Univ Of Saskatchewan |
Combination adjuvant composition
|
|
WO2010049438A2
(en)
*
|
2008-10-30 |
2010-05-06 |
Innate Pharma |
Improved methods of using phosphoantigens for the treatment of diseases
|
|
SG171914A1
(en)
|
2008-12-02 |
2011-07-28 |
Chiralgen Ltd |
Method for the synthesis of phosphorus atom modified nucleic acids
|
|
AU2009325950B2
(en)
|
2008-12-09 |
2013-03-07 |
Pfizer Vaccines Llc |
IgE CH3 peptide vaccine
|
|
KR101450958B1
(ko)
|
2009-04-30 |
2014-10-15 |
콜레이 파마시티컬 그룹, 인코포레이티드 |
폐렴구균 백신 및 그의 용도
|
|
IN2012DN00720A
(enExample)
|
2009-07-06 |
2015-06-19 |
Ontorii Inc |
|
|
EP3358008A1
(en)
|
2009-09-03 |
2018-08-08 |
Pfizer Vaccines LLC |
Pcsk9 vaccine
|
|
HUE032860T2
(en)
|
2010-02-12 |
2017-11-28 |
Chimerix Inc |
A method for treating a virus infection
|
|
US9278135B2
(en)
|
2010-04-26 |
2016-03-08 |
Chimerix Inc. |
Methods of treating retroviral infections and related dosage regimes
|
|
CA2800158C
(en)
|
2010-05-28 |
2020-07-21 |
Coley Pharmaceutical Group, Inc. |
Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules
|
|
EP2575868A1
(en)
|
2010-06-07 |
2013-04-10 |
Pfizer Vaccines LLC |
Ige ch3 peptide vaccine
|
|
WO2012039448A1
(ja)
|
2010-09-24 |
2012-03-29 |
株式会社キラルジェン |
不斉補助基
|
|
EP2680883B1
(en)
|
2011-03-02 |
2018-09-05 |
Pfizer Inc |
Pcsk9 vaccine
|
|
EP2508530A1
(en)
|
2011-03-28 |
2012-10-10 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Purification of triphosphorylated oligonucleotides using capture tags
|
|
RU2606114C2
(ru)
|
2011-06-01 |
2017-01-10 |
Джейнус Байотерапьютикс, Инк. |
Новые модуляторы иммунной системы
|
|
CA2837207A1
(en)
|
2011-06-01 |
2012-12-06 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
|
WO2013007703A1
(en)
|
2011-07-08 |
2013-01-17 |
Universität Zürich |
CLASS A CpG OLIGONUCLEOTIDES FOR PREVENTION OF VIRAL INFECTION IN CATS
|
|
MX347361B
(es)
|
2011-07-19 |
2017-04-12 |
Wave Life Sciences Ltd |
Metodos para la sintesis de acidos nucleicos funcionalizados.
|
|
US9873694B2
(en)
|
2011-10-04 |
2018-01-23 |
Janus Biotherapeutics, Inc. |
Imidazole quinoline-based immune system modulators
|
|
EP2872147B1
(en)
|
2012-07-13 |
2022-12-21 |
Wave Life Sciences Ltd. |
Method for making chiral oligonucleotides
|
|
EP2872485B1
(en)
|
2012-07-13 |
2020-12-16 |
Wave Life Sciences Ltd. |
Asymmetric auxiliary group
|
|
AU2013287630B2
(en)
*
|
2012-07-13 |
2017-05-25 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant
|
|
EP2712870A1
(en)
|
2012-09-27 |
2014-04-02 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Novel RIG-I ligands and methods for producing them
|
|
JPWO2015108048A1
(ja)
*
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
|
US10144933B2
(en)
|
2014-01-15 |
2018-12-04 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
|
EP3095460A4
(en)
*
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
|
CN106068325B
(zh)
|
2014-01-16 |
2021-07-09 |
波涛生命科学有限公司 |
手性设计
|
|
US10279019B2
(en)
|
2014-02-11 |
2019-05-07 |
Stc.Unm |
PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same
|
|
US10434064B2
(en)
|
2014-06-04 |
2019-10-08 |
Exicure, Inc. |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
WO2016029077A1
(en)
|
2014-08-22 |
2016-02-25 |
Janus Biotherapeutics, Inc. |
Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
|
WO2017011918A1
(en)
|
2015-07-22 |
2017-01-26 |
University Of Saskatchewan |
Mycoplasma bovis vaccines and uses thereof
|
|
WO2017121494A1
(en)
*
|
2016-01-15 |
2017-07-20 |
Riboxx Gmbh |
5'-triphosphated short immunostimulatory nucleotides, oligonucleotides and polynucleotides
|
|
US11866700B2
(en)
|
2016-05-06 |
2024-01-09 |
Exicure Operating Company |
Liposomal spherical nucleic acid (SNA) constructs presenting antisense oligonucleotides (ASO) for specific knockdown of interleukin 17 receptor mRNA
|
|
WO2017201390A1
(en)
|
2016-05-19 |
2017-11-23 |
The Regents Of The University Of Michigan |
Novel adjuvant compositions
|
|
JP2019520339A
(ja)
|
2016-06-03 |
2019-07-18 |
ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． |
オリゴヌクレオチド、その組成物および方法
|
|
CN108567977B
(zh)
*
|
2017-03-13 |
2022-04-12 |
复旦大学 |
一种免疫增强剂、免疫治疗药物组合物及其制备与用途
|
|
US11696954B2
(en)
|
2017-04-28 |
2023-07-11 |
Exicure Operating Company |
Synthesis of spherical nucleic acids using lipophilic moieties
|
|
MX2020006243A
(es)
*
|
2017-12-15 |
2020-09-03 |
Bayer Animal Health Gmbh |
Oligonucleotidos inmunoestimulantes.
|
|
WO2019173438A1
(en)
|
2018-03-06 |
2019-09-12 |
Stc. Unm |
Compositions and methods for reducing serum triglycerides
|
|
CN112423766A
(zh)
*
|
2018-07-19 |
2021-02-26 |
一般财团法人阪大微生物病研究会 |
含有A型CpG寡脱氧核糖核苷酸的脂质颗粒
|
|
AU2021258911A1
(en)
|
2020-04-20 |
2022-11-24 |
The University Of British Columbia |
Compositions and methods for preventing, controlling and diagnosing mycobacterial infections
|
|
EP3909612A1
(en)
|
2020-05-12 |
2021-11-17 |
Life Science Inkubator Betriebs GmbH & Co. KG |
Composition of nanoparticles
|